Christopher R. Cline sold $3.1M of Travere Therapeutics, Inc. (TVTX) stock

Christopher R. Cline, Chief Financial Officer of Travere Therapeutics, Inc. (TVTX), sold 50,508 shares of TVTX stock worth $3.1M, per an SEC Form 4 filed Sep 18, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 15, 2026, 3 days before it was made public.

TVTX has moved +0.6% since the trade date, from $62.51 to $62.86 (Sep 21, 2026 close).